How Low Oxygen Shields Prostate Cancer from Ferroptosis Therapies
Nov 6, 2025
Prostate cancer remains a formidable challenge, especially in low-oxygen environments. Researchers reveal how hypoxia allows cancer cells to resist ferroptosis, a potent treatment method aimed at destroying them. In these oxygen-poor areas, lipid metabolism shifts towards stable fats, making cells less susceptible to therapies. The study suggests innovative strategies, combining ferroptosis drugs with lipid storage inhibitors to enhance treatment efficacy. Insights gained could also apply to other solid tumors facing similar hypoxic challenges.
03:49
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Hypoxia Rewires Lipids To Evade Ferroptosis
Hypoxia makes prostate tumors less sensitive to ferroptosis by altering lipid metabolism and storage.
Cancer cells reduce fragile polyunsaturated fats and increase stable lipids to survive low-oxygen stress.
insights INSIGHT
Drug Resistance Linked To Enzyme Changes
Prostate cancer cells become resistant to Erastin and RSL3 in low-oxygen environments.
Hypoxia lowers ECSL4 and LPCAT3 activity and decreases oxidation-prone phosphatidylethanolamines.
insights INSIGHT
Lipid Droplets Act As Protective Shelters
Lipid droplets act as protective storage that shield vulnerable membrane fats from oxidative damage.
Cells increase cholesterol esters and triglycerides in hypoxia to stabilize membranes.
Get the Snipd Podcast app to discover more snips from this episode
Prostate cancer is one of the most common cancers in men. While treatment options have improved, advanced stages of the disease remain difficult to manage. One promising approach involves a process called ferroptosis. This is a type of programmed cell death that relies on iron and lipid oxidation to kill cancer cells by damaging specific fats in their outer membrane. These fats are especially vulnerable in environments with normal oxygen levels.
However, many prostate tumors grow in low-oxygen areas of the body, a condition known as hypoxia, where ferroptosis becomes less effective. A recent study, titled “Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer,” and published on Oncotarget (Volume 16), explores how oxygen-poor environments help prostate cancer cells resist treatment and what strategies could help overcome this resistance.
Full blog - https://www.oncotarget.org/2025/11/06/how-low-oxygen-shields-prostate-cancer-from-ferroptosis-therapies/
Paper DOI - https://doi.org/10.18632/oncotarget.28750
Correspondence to - Noel A. Warfel - warfelna@arizona.edu, and Shailender S. Chauhan - shailenderc@arizona.edu
Abstract video - https://www.youtube.com/watch?v=xFypDT4ALmc
Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28750
Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/
Keywords - cancer, hypoxia, lipid droplets, ferroptosis, resistance, prostate
To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:
Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh
MEDIA@IMPACTJOURNALS.COM
Oncotarget